Syncona Shs GBP ( (GB:SYNC) ) has shared an announcement.
Syncona Limited announced the purchase of 150,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were acquired at a price of 95.7971 GBp each and will be held in treasury, impacting the company’s total voting rights and share capital structure. This move is part of Syncona’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Syncona Shs GBP
Syncona Limited is a prominent life science investor dedicated to creating, building, and scaling a portfolio of global leaders in the life sciences sector. The company focuses on developing transformational treatments for patients with high unmet needs by partnering with world-class academic founders and experienced management teams. Syncona aims to maintain a diversified portfolio of 20-25 leading life science businesses across various development stages, modalities, and therapeutic areas, with a strategy underpinned by a strong balance sheet to deliver long-term returns to shareholders.
YTD Price Performance: -9.56%
Average Trading Volume: 737,399
Technical Sentiment Consensus Rating: Buy
For an in-depth examination of SYNC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com